Stock Evaluator: Canopy Growth Corporation (CGC)

Canopy Growth Corporation CGC

$0.92 0.00 -0.08%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 2,037,987
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Pharmaceuticals

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R’belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Commentary & Analysis


Financial Summary

Share Statistics CGC Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $388.4 $579.1 35%
Shares Out (Mil) 275.8 43.0 82%
Institutional Ownership 97.3% 84.3% 73%
Float (Mil) 421.3 46.8 84%
Beta 2.41 0.62 96%
Avg Daily Volume (000s) 2,301 285 84%
Price Change
(52-week)
(12.6%) 63.8% 36%
Growth CGC Industry
Median
Percentile
(All Stocks)
Sales (5yr) (14.0%) 6.7% 4%
Net Income (5yr) 32.9% (1.4%) 87%
EPS (5yr) 55.8% 14.9% 95
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 17.2% (14.9%) 77%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na 2
Current EPS ($0.061) ($0.336) ($0.107)
Month Ago EPS na na ($0.107)
# Rev Up 0 0 1
# Rev Down 0 1 0
Three Months Ago EPS na na na
Year/Year Chg (79.1%) (46.8%) (80.9%)
Financials CGC Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $204 $272 32%
Net Income (TTM) (Mil) ($188) ($11) 7%
EPS (TTM) ($0.632) ($0.500) 26%
Operating Cash Flow (TTM) (Mil) ($46) ($6) 9%
Net Cash Flow (TTM) (Mil) $181 $4 84%
Long-Term Debt (Q1) (Mil) $178 $7 49%
Enterprise Value (Q1) (Mil) $343 $522 31%
Valuation CGC Industry
Median
Percentile
(All Stocks)
P/B 0.78 2.73 16%
P/E na 20.5 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.2 na
Ratios CGC Industry
Median
Percentile
(All Stocks)
Gross Margin 28.0% 65.9% 32%
Net Margin (92.4%) 0.7% 8%
ROA (26.2%) (24.6%) 18%
ROE (45.2%) (19.7%) 16%
Liabilities to Assets 37.6% 35.5% 28%
F-Score 4 3 34%

Canopy Growth Corporation did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors